Income Statement
GRI BIO, INC.
GRI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
11.98 | 8.24 | 11.39 | 6.93 | 9.26 |
|
Research & Development
|
6.82 | 3.77 | 3.23 | 1.17 | 5.19 |
|
Selling, General & Administrative
|
5.16 | 4.47 | 8.16 | 5.76 | 4.07 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-11.98 | -8.24 | -11.39 | -6.93 | -9.26 |
|
Non-Operating Income
|
- | - | - | - | - |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | 0.00 | 0.25 | 0.00 | 0.06 |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-11.96 | -8.21 | -13.04 | -7.02 | -9.30 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-11.98 | -8.24 | -11.39 | -6.93 | -9.26 |
|
Earnings Per Share (Basic)
|
-121.80 | -55.21 | -28.25 | -0.69 | -1.42 |
|
Diluted EPS
|
-121.80 | -55.21 | -28.25 | -0.69 | -1.42 |
|
Weighted Average Shares
|
0.10 | 0.18 | 0.46 | 10.14 | 6.54 |
|
Diluted Weighted Avg Shares
|
0.10 | 0.18 | 0.46 | 10.14 | 6.54 |
|
Comprehensive Income
|
- | - | - | -7.02 | -9.31 |